India’s pharma and healthcare sector recorded 65 deals worth USD 13.9 billion in Q2 2026, with record M&A values driven by strategic acquisitions and continued investor focus on specialty pharma, AI-enabled healthcare and innovation-led businesses.
Pharmaceutical Industry India | 24/07/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy